United Therapeutics
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About United Therapeutics
United Therapeutics Corp. 是一家生物技術公司，致力於為患有慢性和危及生命的疾病患者開發和商業化產品。其產品包括 Adcirca、Orenitram、Remodulin、TYVASO 和 Unituxin。該公司由 Martine A. Rothblatt 於 1996 年 6 月 26 日創立，總部位於馬裡蘭州銀泉。
如何購買 United Therapeutics (UTHR)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 UTHR
透過 RockFlow App 或網頁端搜尋 UTHR，輸入您想要投資的金額，然後點擊確認即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.